Analytical and bioanalytical chemistry

• 

  Año 2003, Vol. 377, Número 5

  • Wolfish behavior...the successful scientist as leader of a pack or a lone wolf

    John Fetzer

    págs. 785-786

    

  • Current trends in pharmaceutical analysis

    A. Roda

    pág. 787

    

  • Fast LC/MS in the analysis of small molecules

    L. A. Romanyshyn, P. R. Tiller

    págs. 788-802

    

  • New approaches to chromatographic determination of lipophilicity of xenobiotics

    Roman Kaliszan

    págs. 803-811

    

  • Protein microarrays: new tools for pharmaceutical development

    K. D. Kumble

    págs. 812-819

    

  • Microchip PCR

    L. J. Kricka

    págs. 820-825

    

  • Bioluminescence and chemiluminescence in drug screening

    Massimo Guardigli, A. Roda

    págs. 826-833

    

  • Label-free screening of bio-molecular interactions

    M. A. Cooper

    págs. 834-842

    

  • Methodological approaches for the study of GABA~A receptor pharmacology and functional responses

    P. B. Simpson, A. J. Smith

    págs. 843-851

    

  • Chemical and analytical characterization of related organic impurities in drugs

    S. Görög

    págs. 852-862

    

  • An overview of qualimetric strategies for optimisation and calibration in pharmaceutical analysis using flow injection techniques

    Juan Manuel Bosque Sendra

    págs. 863-874

    

  • Study of donepezil binding to serum albumin by capillary electrophoresis and circular dichroism

    R. Gotti, V. Andrisano, C. Bertucci

    págs. 875-879

    

  • Rapid analysis of fluoxetine and its metabolite in plasma by LC-MS with column-switching approach

    S. Souverain

    págs. 880-885

    

  • Determination of serum D-lactic and L-lactic acids in normal subjects and diabetic patients by column-switching HPLC with pre-column fluorescence derivatization

    T. Fukushima, H. Hasegawa

    págs. 886-891

    

  • Monolithic silica columns with chemically bonded beta-cyclodextrin as a stationary phase for enantiomer separations of chiral pharmaceuticals

    K. Nakanishi, D. Lubda, K. Cabrera

    págs. 892-901

    

  • Non-particulate (continuous bed or monolithic) restricted-access reversed-phase media for sample clean-up and separation by capillary-format liquid chromatography

    R. Jarmalaviciene

    págs. 902-908

    

  • Hyphenation of liquid chromatography to ion-trap mass spectrometry to identify minor components in polypeptide antibiotics

    Cedric Govaerts

    págs. 909-921

    

  • Design of luminescent biochips based on enzyme, antibody, or DNA composite layers

    C. A. Marquette

    págs. 922-928

    

  • Enhanced sensitivity electrochemical assay of low-molecular-weight heparins using rotating polyion-sensitive membrane electrodes

    X. K. Ping, Q. Wei, Z. Wei, M. E. Meyerhoff

    págs. 929-936

    

  • How experimental design can improve the validation process. Studies in pharmaceutical analysis

    S. Furlanetto, S. Orlandini

    págs. 937-944